Century Therapeutics, Inc. (IPSC:NASDAQ) closed at $1.65 on November 13, 2026, up 1.23% on the day. The stock trades 45.7% below its 52-week high of $3.04 and 279.3% above its 52-week low of $0.435. Over the past year, it gained 243.8%. Century Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, IPSC closed higher on 118 days (47%). Its best day was January 7, 2026 (+44.44%) and its worst was November 13, 2025 (-17.41%). The stock moved 10% or more in a single session 20 times. It opened at least 5% above the previous day's high 2 times.
Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a significant unmet medical need. It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematological malignancies.
Find more stocks like IPSC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.